Beruflich Dokumente
Kultur Dokumente
Learning Objectives
Describe the Epidemiology, Etiology, Pathogenesis and clinical features of hyperparathyroidism. Name different types of hyperparathyroidisms and their Lab findings. Briefly describe etiology, clinical features and lab findings of different types of hypoparathyroidism. Briefly discuss:
6x4x1 mm
Parathyroid hormone.contd
PTH is a single-chain polypeptide of 84 amino acids The effects of PTH are initiated by binding of PTH to PTH receptors in the target tissues (type 1) The PTH receptor is a seven-transmembrane Gprotein-coupled receptor Hormone binding leads to activation of stimulatory Gprotein Leads to generation of c-AMP
2. Renal actions of PTH PTH acts on distal tubules to stimulate calcium absorption at DCT It inhibits proximal reabsorption of Phosphate
*Net result of these activities is an increase in the level of free Ca, which in turn, inhibits further PTH
secretion in a classic feedback loop
More than 99% of total body Ca is in bone. Prolonged exposure of bone to high levels of PTH is associated with increased osteoclastic activity and new bone formation. But the net effect is to cause bone loss with mobilization of Ca into the ECF. In contrast, pulsatile release of PTH causes net bone gain, an effect used therapeutically in the treatment of osteoprosis
Kidney
Plasma PTH
Bones
Negative
Plasma Ca++
Calcium-PTH interactions
The PTH responds to hypocalcemia
Serum ionized calcium concentration be maintained within a very narrow range Seconds to minutes- exocytosis of PTH Minutes to 1 hour- reduction in intracellular PTH degraded Hours to days- increase in PTH gene expression Days to weeks- proliferation of parathyroid cells
Hyperparathyroidism
A clinical syndrome causing signs and symptoms that result from PTH, PTH induced bone resorption and hypercalcemia Three types of hyperparathyroidism - Primary - Secondary - Tertiary (less common)
Primary Hyperparathyroidism
A common endocrine disorder and is usually due to autonomous, spontaneous overproduction of PTH An important cause of hypercalcemia Epidemiology Overall incidence is 42 in 100,000 Prevalence is 1:1000 Female to male ratio is 3:1 Disease of the adults, 90% patients are over 50yrs of age
..parathyroid adenoma (which can vary in diameters from few mm to several cm): 80%
Inversion of a proto-oncogene Parathyroid adenoma 1 (PRAD1) leads to over expression of Cyclin D 1 protein , forcing the cells of parathyroid gland to proliferate
Primary hyperparathyroidism also occurs in familial MEN syndromes, when hyperplasia or multiple adenomas of all four parathyroid glands rather than a solitary adenoma are more likely Genetic syndromes associated with familial primary hyperparathyroidism include : inactivated Pituitary adenoma (60%) Pancreatic endocrine tumor (75%) Parathyroid neoplasia (90%)
mutations in
Clinical Course
Asymptomatic Hyperparathyroidism
identified after routine chemistry profilehigh ionized serum Ca
Other causes of hypercalcemia e.g., malignancy should be excluded by appropriate clinical and lab investigations .
In Primary hyperthyroidism, levels are inappropriately elevated for the level of serum calcium low to undetectable PTH levels in hypercalcemia because of nonparathyroid disease. In primary hyperparathyroidism Hypercalcaemia, Hypophosphatemia, and increased urinary excretion of Ca and PO4 Secondary renal disease may lead to PO4 retention with normal serum PO4
Clinical Course
Symptomatic Primary Hperparathythyroidism
Combined effects of increased PTH secretion and Hypercalcemia Hyperpparathyroidism: nephrolithiasis and bone disease Hypercalcemia: fatigue, weakness and constipation Classic phrase of these features is renal stones, painful bones, abdominal groans and psychic moans
Bone pain, Fractures, arthralgias Stones, polyuria Pain, duodenal ulcer, pancreatitis
Neurological
Cardiac
Depression, apathy
Hypertension, heart block
Hypercalcemia:Causes
Important
Malignancy is the most common cause of clinically apparent hypercalcaemia Primary hyperparathyroidism is a more common cause of asymptomatic elevated blood calcium
Radiological Features
usually
normal
in
mild
charecteristic
changes
are
in early stages demineralization, with subperiosteal erosions and terminal resorption in the phalanges A pepper-pot appearance may be seen on lateral x-rays of the skull Reduced bone mineral density, resulting in either osteopenia or osteoporosis, is now the most common skeletal manifestation of hyperparathyroidism and it requires assessment by DEXA scan
Secondary Hyperparathyroidism
Caused by any condition associated with a chronic depression in the serum Ca level because low serum Ca leads to compensatory over activity of parathyroid glands. Renal failure is by far the most common cause of secondary hyperparathyroidism Other diseases:
Inadequate dietary intake of Ca, Steatorrhoea, and Vit D deficiency, may also cause this disorder
In CRF reduced GFR leads to reduced inorganic phosphate excretion and consequent hyperphosphatemia Retained phosphate 1. has a direct stimulatory effect on PTH synthesis 2. Also causes lowering of ionized Ca++ and suppression of 1,25(OH)D production 3. Low calcitriol [1,25(OH)D] levels lead to hyperparathyroidism: Calcitriol have a direct suppressive effect on PTH transcription and therefore reduced Calcitriol in CRD causes elevated levels of PTH 4. Impaired Ca ++ absorption from the GI tract, thereby leading to hypocalcemia, increases PTH secretion and production
Clinical features
Usually dominated by those associated with CRF Bone abnormalities(renal osteodystrophy) and other changes associated with PTH excess are in general less severe
Tertiary Hyperparathyroidism
Develops in minority of patients with long-standing secondary hyperparathyroidism commonly seen in advanced CKD. In these patients, continous stimulation of parathyroids over a prolonged period of time results in adenoma formation and autonomous PTH secretion, with resultant hypercalcemia. A clue to the diagnosis of tertiary hyperparathyroidism is intractable hypercalcemia and/or an inability to control osteomalacia despite vitamin D therapy
Primary
N N N
Secondary Tertiary
Hypoparathyroidism
Etiology
a. Surgical hypoparathyroidism Most common cause is neck surgery e.g. total thyroidectomy
b. Idiopathic hypoparathyroidism Age of onset is 2-10 years Female preponderance Circulating parathyroid Ab common c. Familial hypoparathyroidism Autosomal dominant Mutation in PTH gene leads to defective PTH d. Autoimmune hypoparathyroidism
Prominent component of autoimmune polyglandular syndrome Associated with primary adrenal insufficiency, mucocutaneous candidiasis Age of onset 5-9 years
e. Di Georges syndrome f. Congenital aplasia of the parathyroids g. Iron deposition in the glands h. Copper deposition i. Aluminium deposition j. Infiltration with metastatic carcinoma k. Magnesium depletion
Hypoparathyroidism
Acute Hypocalcemia: Parathyroidectomy PTH undetectable at 8 hours Normalizes by 30 hours Calcium nadir at 2000 hours, normal in 2-3 days Medications: I-131, Cimetidine, Cisplatin, Digoxin, Ampho-B Hypomagnesemia Hypermagnesemia
Hereditary Hypoparathyroidism
DiGeorges syndrome agenesis Pseudohypoparathyroidism end-organ resistance to PTH.
Serum PTH levels are normal or elevated. Inability of PTH to generate urinary cyclic AMP
short digits, ectopic calcification Pseudopseudohypoparathyroidism: Variant of Pseudohypoparathyroidism No Hypocalcemia or raised PTH
HYPOPARATHYROIDISM
Hypoparathyroidism
N N
Pseudohypoparathyroi dism
Renal disease
Thank you!
Questions?